Product Code: ETC9967693 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Hereditary Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Hereditary Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Hereditary Testing Market - Industry Life Cycle |
3.4 United States (US) Hereditary Testing Market - Porter's Five Forces |
3.5 United States (US) Hereditary Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) Hereditary Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 United States (US) Hereditary Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about genetic diseases and the importance of early detection |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Advancements in technology leading to more accurate and affordable testing options |
4.3 Market Restraints |
4.3.1 Concerns over data privacy and genetic discrimination |
4.3.2 Lack of standardized regulations and guidelines for genetic testing |
4.3.3 Limited access to testing for underserved populations |
5 United States (US) Hereditary Testing Market Trends |
6 United States (US) Hereditary Testing Market, By Types |
6.1 United States (US) Hereditary Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Hereditary Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) Hereditary Testing Market Revenues & Volume, By Hereditary Cancer Testing, 2021- 2031F |
6.1.4 United States (US) Hereditary Testing Market Revenues & Volume, By Hereditary Non-cancer Testing, 2021- 2031F |
6.2 United States (US) Hereditary Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Hereditary Testing Market Revenues & Volume, By Cytogenetic, 2021- 2031F |
6.2.3 United States (US) Hereditary Testing Market Revenues & Volume, By Biochemical, 2021- 2031F |
6.2.4 United States (US) Hereditary Testing Market Revenues & Volume, By Molecular Testing, 2021- 2031F |
7 United States (US) Hereditary Testing Market Import-Export Trade Statistics |
7.1 United States (US) Hereditary Testing Market Export to Major Countries |
7.2 United States (US) Hereditary Testing Market Imports from Major Countries |
8 United States (US) Hereditary Testing Market Key Performance Indicators |
8.1 Adoption rate of genetic testing in different demographic segments |
8.2 Rate of reimbursement for genetic testing by insurance companies |
8.3 Number of partnerships between genetic testing companies and healthcare providers |
9 United States (US) Hereditary Testing Market - Opportunity Assessment |
9.1 United States (US) Hereditary Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) Hereditary Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 United States (US) Hereditary Testing Market - Competitive Landscape |
10.1 United States (US) Hereditary Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Hereditary Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |